Answers are grounded in this paper and cite their sources.
There is a new wave of aspiration risk heading towards our operating theatres in the coming years. The popular weight loss drugs, glucagon-like peptide (GLP-1) receptor agonists, are providing us with new dilemmas in fasting guidelines and airway management. What does the anaesthetic team need to know?
No takes yet. Share an insight, caveat, or question.
Madden et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: